OTCMKTS:ULUR - Uluru Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0450 -0.01 (-18.18 %) (As of 03/25/2019 04:00 PM ET)Previous Close$0.05Today's Range$0.0450 - $0.045052-Week Range$0.0310 - $0.10Volume8,166 shsAverage Volume2,813 shsMarket Capitalization$9.06 millionP/E RatioN/ADividend YieldN/ABeta2.03 ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. and is headquartered in Addison, Texas. Receive ULUR News and Ratings via Email Sign-up to receive the latest news and ratings for ULUR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ULUR Previous Symbol CUSIPN/A CIK1168220 Webwww.uluruinc.com Phone214-905-5145Debt Debt-to-Equity RatioN/A Current Ratio1.47 Quick Ratio1.29Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$720,000.00 Price / Sales12.58 Cash FlowN/A Price / Cash FlowN/A Book Value$0.03 per share Price / Book1.50Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-1,930,000.00 Net Margins-387.25% Return on Equity-42.20% Return on Assets-28.24%Miscellaneous Employees2 Outstanding Shares201,350,000Market Cap$9.06 million Next Earnings Date3/29/2019 (Estimated) OptionableNot Optionable Uluru (OTCMKTS:ULUR) Frequently Asked Questions What is Uluru's stock symbol? Uluru trades on the OTCMKTS under the ticker symbol "ULUR." When is Uluru's next earnings date? Uluru is scheduled to release their next quarterly earnings announcement on Friday, March 29th 2019. View Earnings Estimates for Uluru. Has Uluru been receiving favorable news coverage? Headlines about ULUR stock have been trending positive recently, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Uluru earned a news impact score of 2.3 on InfoTrie's scale. They also gave press coverage about the specialty pharmaceutical company a news buzz of 7.0 out of 10, meaning that recent media coverage is likely to have an effect on the company's share price in the next few days. Who are some of Uluru's key competitors? Some companies that are related to Uluru include ContraFect (CFRX), Oncomed Pharmaceuticals (OMED), Achaogen (AKAO), Advaxis (ADXS), Oncolytics Biotech (ONCY), Addex Therapeutics (ADDXF), MOTIF BIO PLC/S (MTFB), OncoSec Medical (ONCS), Sophiris Bio (SPHS), Adial Pharmaceuticals (ADIL), GTX (GTXI), Heat Biologics (HTBX), RegeneRx Biopharmaceuticals (RGRX), Q BioMed (QBIO) and Aileron Therapeutics (ALRN). What other stocks do shareholders of Uluru own? Based on aggregate information from My MarketBeat watchlists, some companies that other Uluru investors own include Synergy Pharmaceuticals (SGYP), Integral Technologies (ITKG), Infinite Group (IMCI), IntelliPharmaCeutics Intl (IPCI), Tethys Petroleum (TPL), Aeolus Pharmaceuticals (AOLS), China Auto Logistics (CALI), Net Medical Xpress Solutions (NMXS), Consolidated Water (CWCO) and E-QURE (EQUR). Who are Uluru's key executives? Uluru's management team includes the folowing people: Ms. Vaidehi A. Shah, Chairman & CEO (Age 42)Mr. P. K Ramachandran, Chief Financial Officer (Age 65) How do I buy shares of Uluru? Shares of ULUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Uluru's stock price today? One share of ULUR stock can currently be purchased for approximately $0.0450. How big of a company is Uluru? Uluru has a market capitalization of $9.06 million and generates $720,000.00 in revenue each year. Uluru employs 2 workers across the globe. What is Uluru's official website? The official website for Uluru is http://www.uluruinc.com. How can I contact Uluru? Uluru's mailing address is 4410 BELTWAY DRIVE, ADDISON TX, 75001. The specialty pharmaceutical company can be reached via phone at 214-905-5145. MarketBeat Community Rating for Uluru (OTCMKTS ULUR)Community Ranking: 1.5 out of 5 ( )Outperform Votes: 28 (Vote Outperform)Underperform Votes: 65 (Vote Underperform)Total Votes: 93MarketBeat's community ratings are surveys of what our community members think about Uluru and other stocks. Vote "Outperform" if you believe ULUR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ULUR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/25/2019 by MarketBeat.com StaffFeatured Article: What is the S&P 500 Index?